Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.620EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.2.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDMEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.16 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.10.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.5 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.34.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.2.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.9.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.55EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.39EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XWEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KG.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDJEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.3.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.5.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.36.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.86.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.58 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.21EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CP.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBGEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.98 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDTEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.21EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.617.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.109 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.2.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.2.3 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.8 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.617.1 (Kappa)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.3 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.46.5 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Q.4 (Alpha)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.442EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.1 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used